![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.40 | 4.30 | 4.50 | 4.40 | 4.40 | 4.40 | 291,809 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.48 | 23.47M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/9/2023 09:34 | Best Guess. My credibility is not in doubt as your question illuminates perfectly. | ![]() supersonico | |
28/9/2023 09:25 | Watch out everyone Supersonico just spent their pocket money to buy 192 shares. Ad Astra per aspera | ![]() ravenna23 | |
28/9/2023 09:25 | Eden well funded now. Rest of fundraise circa 9M coming in soon following court approval and registration at companies house. | ![]() babysitter | |
28/9/2023 09:23 | For all you traders out there, if you can buy shares at less than the mid price, the price is on the way down. NB trades of 50000 plus do not have to be declared immediately, they can delay declaration. Edens NMS normal market size is 50000. | ![]() ravenna23 | |
28/9/2023 09:11 | Please answer the question. What price did you pay for your Eden shares? Others need to be able to gauge your credibility, they may not have endured your COVID rantings. | ![]() ravenna23 | |
28/9/2023 09:08 | Best Guess, It's Whale season now. | ![]() supersonico | |
28/9/2023 09:04 | What is the average price you paid for Eden shares? I made a 90% profit when I sold my holding. How are you doing, care to share? | ![]() ravenna23 | |
28/9/2023 08:44 | Best Guess, 'May have got the date wrong' Perhaps a visit to the Collins English Dictionary might help you with the 'may' part of that sentence. More accurate sentence would be; 'Best Guess got the date wrong as well as all other guesses made' Not a good track record. | ![]() supersonico | |
28/9/2023 08:29 | A reality check for all of you dreamers. Eden only raised 1.5m, that is only a few months cash (salary for directors). There has been no further mention of the 9m from EIS schemes. This is probably due to the fact that 3 months after half year end there are still no accounts. Why, because I doubt given Edens financial position even the most optimistic auditor could declare them as a going concern, namely enough money to last a year. No reputable EIS manager will put money into such a company. Your only hope now is that Corteva are feeling generous and buy out Eden. This will be at a lower price than you just paid at the cap raise. However I still think Edens will go into administration or be taken private. May have got the date wrong, but yet to be proved wrong.The directors of Eden are doing shareholders no favours whatsoever. Hopium is the only thing for holders. | ![]() ravenna23 | |
28/9/2023 08:26 | Alchemy 'crunch' is not the sound I associate with Whales. | ![]() supersonico | |
27/9/2023 18:51 | James Hourston who has previously worked with Syngenta at Royal Holloway (see post-15288 ) is now keen to employ an Entomologist ... a person who studies or is an expert in the branch of zoology concerned with insects. Eden Research plc Milton, England, United Kingdom (On-site) £27K/yr - £37K/yr About the job Eden Research plc is a rapidly expanding company, recently invigorated by significant capital investment from new and existing shareholders. The Company provides sustainable solutions for challenges in crop protection through the development of biopesticides, these products are based upon two key technology platforms: plant-derived active ingredients with a broad range of biological activity and a patented microencapsulation technology derived from yeast extract. As a scientist in the biological efficacy team you will be responsible for supporting the successful delivery of key projects within the company. The role will require technical know-how and innovation. Responsibilities: Continuing to develop our biological testing capacity by running efficacy focused assays, maintaining cultures of insects, plants. Designing and optimising protocols / SOPs backed up by literature searches to explore methodologies / knowledge of important agricultural pests. Testing and validating biological test protocols (experience handling PPPs, entomology experience) Analysing internal and external trials data (familiarity with statistical analysis methods and software packages) Presenting research findings to the wider team in a concise and compelling manner Liaising with CROs to design trials (relationship management / familiarity with EPPO guidelines / good experimental design) Reviewing external reports to ensure contractors have delivered to scope (demonstrating attention to detail) | ![]() supersonico | |
27/9/2023 16:25 | Aye crunch time ! Next three months ? But you're so collegiate and polite! | ![]() alchemy | |
27/9/2023 10:27 | Anyone recall " buying for the new account?"What about the next quarter ? I think that still exists . | ![]() alchemy | |
26/9/2023 20:17 | Sooooooo Neutsy | ![]() timbo_slice | |
26/9/2023 18:44 | > As always, I'm looking forward to your in-depth analysis and research. Then you are as daft as he is | ![]() kittybiscuits | |
26/9/2023 13:44 | Neuts,Do you think there is any possibility that EDEN have accidentally stumbled across a goldmine of possible opportunity, and despite 20 years of ineptitude that they might end up making a profit? As always, I'm looking forward to your in-depth analysis and research. Benjamin Orwell Trunchbull | ![]() timbo_slice | |
26/9/2023 13:27 | Beyond delusional!! Or perhaps one of the paid scammers. How come these retreads contrive to ignore 20+ years of evidence. Not to mention the share price chart! ;D and popcorn and pressed daisies. | ![]() neutralpov | |
26/9/2023 10:00 | Absorbing the red trades quite well. I guess we'll start discounting the developing news as the final quarter kicks in? Maybe a trading opp at slightly lower levels first? | ![]() alchemy | |
26/9/2023 06:05 | Neuts, I doubt your ability to press a flower. TGWW. | ![]() timbo_slice | |
25/9/2023 21:38 | The Canary that watches the Whales coalesce. Big Ag's --Event 201--The curation of Lockstep. Igor Teslenko 🇺🇦Vi • 3rd+ President Europe, Middle East, Africa at Corteva 12h • Corteva's #GrowingForGood event series launched last week in Brussels, with insightful expert panel discussions on the collaborative and collective potential of the European food industry to help deliver the EU's climate objectives. This series was organized in partnership with the Financial Times and is one of four circular conversations scheduled to examine and explore transitioning and coordinating efforts to achieve maximum progress toward our common sustainability goal. The series will culminate with a closing ceremony, where the knowledge accrued will create a strategic roadmap to guide the food industry's collective journey to sustainability. | ![]() supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions